COVID-19 Supply Chain Management/Drug Shortage

Updates & Resources

• America’s Pharmaceutical Supply and Payment Chain Collaborating to Promote Undisrupted Patient Access to Medications

• COVID-19 and Risks to the Supply and Quality of Tests, Drugs, and Vaccines  

• FDA Relaxes Rules to Make Muscle Relaxers, Drugs for COVID-19 

• Amid Pandemic, FDA Seizes Cheaper Drugs From Canada 

• FDA Relaxes Rules to Make Muscle Relaxers, Drugs for Covid-19 

• COVID-19 and Risks to the Supply and Quality of Tests, Drugs, and Vaccines 

• Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency

• FDA Added Hydroxychloroquine to Category 1 Under the Interim Policy on Compounding Using Bulk Substances 

• Business Continuity Resources for the Supply Chain 

• COVID-19 Supply Chain Resources 

• Current and Resolved Drug Shortages and Discontinuations Reported to FDA